Document is current
Any future updates will be listed below
-
Authors
Liu, Tong https://orcid.org/0000-0001-9234-1328
Wang, Zheng
Ye, Leiguang
Duan, Yuran
Jiang, Hongfei
He, Haiyan
Xiao, Liwei
Wu, Qingang
Xia, Yan
Yang, Mengke
Wu, Ke
Yan, Meisi
Ji, Guimei
Shen, Yuli
Wang, Lei
Li, Lin
Zheng, Peixiang
Dong, Bofei
Shao, Fei https://orcid.org/0000-0002-8742-9197
Qian, Xu
Yu, Rilei
Zhang, Zhiren
Lu, Zhimin https://orcid.org/0000-0002-2859-2736
Xu, Daqian https://orcid.org/0000-0003-0478-2997
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology of the People’s Republic of China (2021YFA0805600, D.X., 2020YFA0803300, Z.L.)
- License Information
-
More Information
Article History
Received: 28 February 2022
Accepted: 24 November 2022
First Online: 16 January 2023
Competing interests
: Z.L. owns shares in Signalway Biotechnology (Pearland, TX), which supplied rabbit antibodies that recognize CLOCK pS106 and PRPS1/2 K29ac. Z.L.’s interest in this company had no bearing on its being chosen to supply these reagents. The remaining authors declare no competing interests.
